Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Cancer. 2012 Apr 19;118(21):5384–5394. doi: 10.1002/cncr.27538

Table 3.

Association between pancreatic cancer and level of serum autoantibody, odds ratios (OR) and 95% confidence intervals (CI) from age and sex-adjusted logistic models

Cases (N=300) Controls (N=300) OR 95% CI P-value
CTDSP1
    Q1 65 89 1.0
    Q2 77 70 1.5 (0.96-2.4)
    Q3 77 75 1.4 (0.90-2.2)
    Q4 81 66 1.7 (1.1 -2.6)
P trend 0.04
MAPK9
    Q1 61 91 1.0
    Q2 69 77 1.3 (0.84-2.1)
    Q3 80 77 1.5 (0.98-2.5)
    Q4 90 55 2.4 (1.5 -3.9)
P trend 0.0002
NR2E3
    Q1 50 89 1.0
    Q2 76 85 1.6 (1.0 -2.5)
    Q3 71 79 1.6 (1.0 -2.6)
    Q4 103 47 4.0 (2.4 -6.5)
P trend <0.0001
CTDSP1
    <Q4 219 234 1.0
    Q4 81 66 1.3 (0.90-1.9)
0.15
MAPK9
    <Q4 210 245 1.0
    Q4 90 55 1.9 (1.3 -2.8)
0.0009
NR2E3
    <Q4 197 253 1.0
    Q4 103 47 2.9 (1.9 -4.3)
<0.0001
No. of AAs with levels in Q4
    0 (none) 158 198 1.0 (referent)
    1 of 3 55 55 1.2 (0.81-1.9)
    2 of 3 42 28 1.9 (1.1 - 3.2)
    3 of 3 45 19 3.0 (1.7 -5.4)
P trend 1.4 (1.2 -1.7) <0.0001

* Autoantibody serum level fit as a continuous variable in age and sex-adjusted logistic model

Q4 = 4th quartile, AAs= autoantibodies